Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) Invested Capital (2016 - 2025)

Historic Invested Capital for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to $3.2 million.

  • STRATA Skin Sciences' Invested Capital fell 6607.81% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 6607.81%. This contributed to the annual value of $5.0 million for FY2024, which is 6081.34% down from last year.
  • STRATA Skin Sciences' Invested Capital amounted to $3.2 million in Q3 2025, which was down 6607.81% from $532000.0 recorded in Q2 2025.
  • In the past 5 years, STRATA Skin Sciences' Invested Capital ranged from a high of $26.2 million in Q3 2021 and a low of $532000.0 during Q2 2025
  • In the last 5 years, STRATA Skin Sciences' Invested Capital had a median value of $16.9 million in 2023 and averaged $15.7 million.
  • Per our database at Business Quant, STRATA Skin Sciences' Invested Capital crashed by 324.45% in 2021 and then plummeted by 9440.35% in 2025.
  • Quarter analysis of 5 years shows STRATA Skin Sciences' Invested Capital stood at $25.4 million in 2021, then fell by 14.1% to $21.8 million in 2022, then plummeted by 41.88% to $12.7 million in 2023, then tumbled by 60.81% to $5.0 million in 2024, then crashed by 35.86% to $3.2 million in 2025.
  • Its Invested Capital stands at $3.2 million for Q3 2025, versus $532000.0 for Q2 2025 and $3.0 million for Q1 2025.